selected scholarly activity
-
conferences
- ROME III Criteria for Functional Gastrointestinal Disorders: Too Much Overlap to Be Useful?. Gastroenterology. S725-S726. 2011
- The Risk of Bacterial Contamination to the Endoscopist and Endoscopy Unit During Routine Esophagogastroduodenoscopy and Colonoscopy. Gastrointestinal Endoscopy. AB232-AB232. 2009
- GERD in Canada. Journal of Clinical Gastroenterology. S51-S53. 2007
- An exploratory, randomised, controlled, parallel-group, open-label study to evaluate different dosing regimens of rabeprazole in controlling nocturnal heartburn (NT HB) symptoms in uninvestigated symptomatic gastroesophageal reflux disease (s-GERD). Gastroenterology. A176-A176. 2006
- Maintenance therapy with continuous and on-demand rabeprazole (RAB) 20mg in uninvestigated gastroesophageal reflux disease. Gastroenterology. A174-A174. 2006
- Night-time heartburn as a possible indicator of degree of heartburn severity, frequency and response to standard acid suppressive regimens. Gastroenterology. A179-A179. 2006
- Upper GI bleeding in Canada: 1993-1994 and 2002-2003. Gastroenterology. A435-A435. 2004
- Cost analysis and quality of life assessments of palliation of malignant dysphagia by Nd:YAG laser. Gastroenterology. A36-A36. 2000
- Palliation of esophageal and colorectal cancer with YAG laser: Quality of life assessments. Gastroenterology. A647-A647. 1998
- Gastrointestinal bleeding in Canadian osteo and rheumatoid arthritis patients.. Gastroenterology. A224-A224. 1997
- Prevalence of Helicobacter pylori in patients presenting with bleeding peptic ulcers.. Gastroenterology. A224-A224. 1997
- A Canadian multi-centre survey of gastrointestinal bleeding: Economic considerations.. Gastroenterology. A201-A201. 1996
- MULTIDISCIPLINARY MULTIMODALITY TREATMENT OF ESOPHAGEAL CANCER. Gastroenterology. A380-A380. 1994
- NSAID AND PEPTIC-ULCER THERAPY IN PATIENTS WITH GASTRODUODENAL ULCER (GU DU). Gastroenterology. A150-A150. 1993
- RATES OF DUODENAL-ULCER (DU) HEALING BY DRUG CLASSES - A METAANALYSIS. Gastroenterology. A150-A150. 1993
- GASTRIC-ACID SUPPRESSION AND HEALING OF GASTROESOPHAGEAL REFLUX DISEASE - CAN PHYSIOLOGICAL-STUDIES PREDICT RESPONSE. Gut. S62-S62. 1992
- HEALTHY-MALES RECEIVING H-2-RECEPTOR ANTAGONIST INFUSION AND PARENTERAL OR ENTERAL FEEDING SHOW NO DIFFERENCES IN PLASMA GASTRIN-LEVELS. Gut. S61-S61. 1992
- GASTROJET INFUSION OF RANITIDINE AND INTRADUODENAL NUTRITION - A MORE RATIONAL PROPHYLAXIS FOR STRESS ULCERATION. Gut. A1221-A1221. 1991
- PALLIATION OF ESOPHAGEAL-CARCINOMA WITH YAG LASER AND ENDOLUMINAL CESIUM RADIATION. Gut. A1192-A1192. 1990
- PALLIATION OF ESOPHAGEAL-CARCINOMA WITH YAG LASER AND ENDOLUMINAL CESIUM RADIATION. Gastrointestinal Endoscopy. 189-190. 1990
- H-2-RECEPTOR ANTAGONIST-ACETAMINOPHEN INTERACTIONS. American Journal of Gastroenterology. 822-822. 1984
-
journal articles
- Poor predictive value of lower gastrointestinal alarm features in the diagnosis of colorectal cancer in 1981 patients in secondary care. Alimentary Pharmacology and Therapeutics. 45:91-99. 2017
- Gastrocolic Fistula: A Shortcut through the Gut. Canadian Journal of Gastroenterology and Hepatology. 2016:1-3. 2016
- Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey. Scandinavian Journal of Gastroenterology, Supplement. 50:816-823. 2015
- No increase in prevalence of somatization in functional vs organic dyspepsia: a cross‐sectional survey. Neurogastroenterology and Motility. 27:1024-1031. 2015
- Irritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating. Alimentary Pharmacology and Therapeutics. 41:449-458. 2015
- The Rome III Criteria for the Diagnosis of Functional Dyspepsia in Secondary Care Are Not Superior to Previous Definitions. Gastroenterology. 146:932-940.e1. 2014
- Characteristics of functional bowel disorder patients: a cross‐sectional survey using the Rome III criteria. Alimentary Pharmacology and Therapeutics. 39:312-321. 2014
- Validation of the Rome III Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care. Gastroenterology. 145:1262-1270.e1. 2013
- Summary of the Canadian Association of Gastroenterology 2004 Strategic Plan. Canadian Journal of Gastroenterology and Hepatology. 24:164-167. 2010
- Survey of Access to GastroEnterology in Canada: The SAGE Wait Times Program. Canadian Journal of Gastroenterology and Hepatology. 24:20-25. 2010
- Maintenance Treatment of Gastroesophageal Reflux Disease: An Evaluation of Continuous and On-Demand Therapy with Rabeprazole 20 mg. Canadian Journal of Gastroenterology and Hepatology. 21:820-826. 2007
- Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome. Transfusion Medicine Reviews. 17:272-286. 2003
- Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome. Transfusion Medicine Reviews. 17:272-286. 2003
- Gastrointestinal Angiodysplasia and Aortic Stenosis. New England Journal of Medicine. 347:858-859. 2002
- Recommendations for the Appropriate Use of Anti-Inflammatory Drugs in the Era of the Coxibs: Defining the Role of Gastroprotective Agents. Canadian Journal of Gastroenterology and Hepatology. 16:231-240. 2002
- Healthcare utilization associated with dyspepsia in patients with arthritis.. American Journal of Managed Care. 5:1285-1295. 1999
- Primary Biliary Cirrhosis and Type II Autoimmune Polyglandular Syndrome. Canadian Journal of Gastroenterology and Hepatology. 13:767-770. 1999
- MEDICAL-MANAGEMENT OF GASTROINTESTINAL-BLEEDING. European Journal of Gastroenterology and Hepatology. 2:73-78. 1990